
Roslyn Mannon
Vice-Chair for Research, Department of Medicine · Duke University Hospital
Credentials: · · · ·
History
PresentDepartment of Medicine · Duke University Hospital
PresentUNMC Department of Internal Medicine · University of Nebraska Medical Center College of Medicine
PresentUNMC Division of Nephrology · University of Nebraska Medical Center College of Medicine
1988–1990

Research
Banff 07 classification of renal allograft pathology: updates and future directions
American Journal of Transplantation · 2008 · 1,572 citations
American Journal of Transplantation · 2018 · 865 citations
American Journal of Transplantation · 2007 · 864 citations

37 papers

29 papers
- DH
23 papers

23 papers

19 papers

17 papers
- WG
17 papers · 1 as a fellow
- RG
15 papers
Grants
- 2024–2029
An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)
Department of Veterans Affairs · I01
Contact PI · Omaha Va Medical Center
- 2017–2028
4/14 APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $1.8M · University of Alabama at Birmingham
- 2016–2022
AMP Kinase Activation in Calcineurin Inhibitor Nephrotoxicity
Department of Veterans Affairs · I01
Contact PI · Omaha Va Medical Center
- 1996–2001
Regulation of Thymocyte Apoptosis by Thromboxane a2
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $366.5K · Duke University
Clinical trials
- 2024–2030
Empagliflozin Treatment in Kidney Transplant Recipients
Principal investigator · Recruiting · Phase 4
VA Office of Research and Development
- 2013–2016
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
Study chair · Terminated · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)


